Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus

BACKGROUND: Our previous research indicated the excellent in vitro antibacterial activity of Eravacycline (Erava) and its heteroresistance frequency against clinical Staphylococcus aureus isolates. In this study, we further aimed to investigate the mechanisms of Erava resistance and heteroresistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhanwen, Lin, Zhiwei, Bai, Bing, Xu, Guangjian, Li, Peiyu, Yu, Zhijian, Deng, Qiwen, Shang, Yongpeng, Zheng, Jinxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329441/
https://www.ncbi.nlm.nih.gov/pubmed/32611319
http://dx.doi.org/10.1186/s12866-020-01869-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329441/
https://www.ncbi.nlm.nih.gov/pubmed/32611319
http://dx.doi.org/10.1186/s12866-020-01869-6

Ejemplares similares